Semaglutide Storage: Refrigeration Guidelines & Stability

Last reviewed: May 20, 2026

Last updated: May 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, compounded semaglutide requires refrigeration between 2–8°C (36–46°F) before first use to maintain stability and potency. Studies show that temperature fluctuations above this range can degrade the peptide structure, potentially reducing therapeutic effectiveness within weeks.

Proper storage directly impacts whether your compounded medication delivers consistent results. Understanding cold-chain requirements alongside your individual metabolic profile—revealed through genetic screening—creates a comprehensive foundation for successful treatment outcomes.

Temperature Requirements and Stability Windows for Compounded Formulations

Compounded semaglutide must remain refrigerated at 2–8°C before opening. Once reconstituted or in use, most formulations maintain stability for 28 days when stored correctly. Temperature excursions even 2–3 degrees above the upper limit can accelerate degradation and reduce bioavailability.

Freezing temperatures should also be avoided, as ice crystal formation can damage the peptide structure irreversibly. A dedicated pharmacy-grade refrigerator, separate from food storage, provides the most consistent temperature environment and reduces contamination risk.

Storage Conditions and Handling Protocols: A Clinical Comparison Framework

Beyond refrigeration, multiple environmental factors determine how long your compounded semaglutide remains therapeutically effective. Light exposure, humidity, and handling frequency all influence peptide stability and injection safety. This framework helps you understand key storage variables and their clinical impact.

Storage Factor	Optimal Condition	Clinical Impact of Deviation
Temperature Range	2–8°C (36–46°F)	Above 8°C: accelerated degradation; below 2°C: crystallization risk
Light Exposure	Store in dark/opaque container	UV exposure degrades peptide within days; amber vials recommended
Humidity Level	30–70% relative humidity	Excess moisture promotes bacterial growth; desiccant packs may be needed
Vial Handling	Minimize needle punctures; use sterile technique	Repeated punctures compromise sterility seal; contamination risk increases exponentially

Post-Reconstitution Timelines and Safe-Use Windows

Once reconstituted with sterile diluent, most compounded semaglutide formulations remain stable for 28 days under refrigeration. Some pharmacies may specify shorter windows (14–21 days) depending on their compounding medium and sterilization protocol. Always verify the exact date with your pharmacy.

After removing from refrigeration for injection, do not return unused portions to the refrigerator. Room-temperature exposure should be limited to 30 minutes maximum. Discard any vial that has been left unrefrigerated for more than 2 hours to prevent bacterial overgrowth and ensure injection safety.

Who Should Prioritize Strict Storage Compliance and When Provider Consultation Matters Most

Patients with limited refrigerator access, frequent travel, or unstable home environments face higher risks of medication degradation and reduced efficacy. If you cannot maintain consistent cold-chain storage, discuss alternative dosing schedules or pre-filled pen options with your healthcare provider before starting treatment.

Individuals with genetic predispositions affecting peptide metabolism—identified through biomarker screening—may experience heightened sensitivity to even minor potency reductions. Provider guidance becomes essential if you have storage constraints or live in climates with temperature volatility.

How PlexusDx Supports a More Personalized Approach

Storage compliance directly intersects with individual metabolic response. PlexusDx genetic screening reveals predispositions in peptide pathways—variants like GLP1R rs6923761 and GIPR rs1800437—that may help provide context for how sensitive your system is to medication potency fluctuations caused by improper storage.

The Precision Peptide Genetic Test identifies genetic markers in peptide-processing pathways. While the test does not predict exact medication response, understanding your genetic predispositions can support a more informed conversation with your provider about storage discipline and whether compounded semaglutide is the optimal choice for your physiology.

Combining strict storage protocols with personalized genetic insights creates a synergistic approach to treatment success. This information should be interpreted with a qualified healthcare provider who can evaluate your storage capacity, genetic predispositions, and overall clinical suitability for compounded therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.